Chemtronics Biomedical Engineering Revenue and Competitors
Estimated Revenue & Valuation
- Chemtronics Biomedical Engineering's estimated annual revenue is currently $42.7M per year.
- Chemtronics Biomedical Engineering's estimated revenue per employee is $251,000
Employee Data
- Chemtronics Biomedical Engineering has 170 Employees.
- Chemtronics Biomedical Engineering grew their employee count by -2% last year.
Chemtronics Biomedical Engineering's People
Name | Title | Email/Phone |
---|---|---|
1 | Service Engineer | Reveal Email/Phone |
Chemtronics Biomedical Engineering Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $17.1M | 68 | -4% | N/A | N/A |
#2 | $26.9M | 107 | 8% | N/A | N/A |
#3 | $24.8M | 99 | 5% | N/A | N/A |
#4 | $19.1M | 76 | 0% | N/A | N/A |
#5 | $30.4M | 121 | 4% | N/A | N/A |
#6 | $74.3M | 296 | N/A | N/A | N/A |
#7 | $40.2M | 160 | 5% | N/A | N/A |
#8 | $74M | 295 | 30% | N/A | N/A |
#9 | $420.2M | 1674 | 8% | N/A | N/A |
#10 | $51.5M | 205 | 1% | N/A | N/A |
What Is Chemtronics Biomedical Engineering?
Provides specialist technical and consulting services to the health and disability sectors through the following business trading names: Chemtronics Biomedical Engineering, Chemtronics Direct, In-A-Tick Compliance Testing Services, Hospitech Facilities and Asset Management and Biomedical Engineering Australia Life Cycle Medical Technology Asset Management, Hospital Development and Planning, Assistive Technologies, Health Facilities Management, Calibration and Compliance, Management Consulting, Health IT Project Management, Logistics and Distribution
keywords:N/AN/A
Total Funding
170
Number of Employees
$42.7M
Revenue (est)
-2%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $36.7M | 230 | 3% | N/A |
#2 | $49.3M | 249 | 0% | N/A |
#3 | $58.2M | 252 | -4% | N/A |
#4 | N/A | 324 | 30% | N/A |
#5 | $461.9M | 1222 | 10% | N/A |